Skip to main content

Table 1 Patient Characteristics

From: Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients

Characteristics

n (%) or Median

Number of eligible patients

328

Leukapheresis

132*

No Leukapheresis

196 (100)

Lack of consent

47 (24)

Inadequate venous access

39 (20)

Pediatric (< 18)

29 (15)

Acute medical illness

11 (5)

Other (scheduling)

70 (36)

Median Age

49.7 (range 18.2–67.7)

Gender Male

80 (61)

Female

52 (39)

Median Karnofsky performance status

80 (range 40–100)

Chronic GVHD Severe

82 (62)

Moderate

46 (35)

Mild

4 (3)

Mean number of organs involved

4.92

Mean lines of prior systemic treatment

3.4

  1. *gender, performance status and chronic GVHD percentages correspond to patients who underwent leukapheresis (n = 132)